Table of Contents

company-logo

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Revolution Medicines Dividend Announcement

• Revolution Medicines does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Revolution Medicines dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Revolution Medicines Dividend History

Revolution Medicines Dividend Yield

Revolution Medicines current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Revolution Medicines stock? Use our calculator to estimate your expected dividend yield:

Revolution Medicines Financial Ratios

P/E ratio-17.83
PEG ratio0.20
P/B ratio6.46
ROE-33.67%
Payout ratio0.00%
Current ratio14.24
Quick ratio14.24
Cash Ratio1.82

Revolution Medicines Dividend FAQ

Does Revolution Medicines stock pay dividends?
Revolution Medicines does not currently pay dividends to its shareholders.
Has Revolution Medicines ever paid a dividend?
No, Revolution Medicines has no a history of paying dividends to its shareholders. Revolution Medicines is not known for its dividend payments.
Why doesn't Revolution Medicines pay dividends?
There are several potential reasons why Revolution Medicines would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Revolution Medicines ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Revolution Medicines has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Revolution Medicines a dividend aristocrat?
Revolution Medicines is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Revolution Medicines a dividend king?
Revolution Medicines is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Revolution Medicines a dividend stock?
No, Revolution Medicines is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Revolution Medicines stocks?
To buy Revolution Medicines you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Revolution Medicines stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.